Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06197685 · ClinicalTrials.gov registry record · NA

A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT06197685 is a NA study of Multiple Sclerosis that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 78 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06197685, a NA study of Multiple Sclerosis, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

The goal of this novel study is to compare the effect of a combined cognitive rehabilitation and exercise approach on new learning and memory (NLM) in persons with multiple sclerosis (pwMS) and mobility disability.

Conditions Studied

Interventions

  • BEHAVIORAL The Kessler Foundation modified Story Memory Technique® (KF-mSMT®)
  • BEHAVIORAL Aerobic Exercise Training (AET) plus Virtual Reality (IDEAL)
  • BEHAVIORAL Stretching and Toning (S/T)

Study Locations (1)

New Jersey

  • Kessler Foundation - East Hanover

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2024-02-12
Est. Completion 2026-06-30
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT06197685

The ClinicalTrials.gov registry entry for NCT06197685 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (87% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 3 interventions - of which The Kessler Foundation modified Story Memory Technique® (KF-mSMT®) is the first listed.

NCT06197685 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06197685 about?

NCT06197685 is a clinical study titled "A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis". The goal of this novel study is to compare the effect of a combined cognitive rehabilitation and exercise approach on new learning and memory (NLM) in persons with multiple sclerosis (pwMS) and mobility disability.

What is the current status of trial NCT06197685?

This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2024-02-12. Estimated completion is 2026-06-30.

What conditions does trial NCT06197685 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT06197685?

The interventions under investigation include: The Kessler Foundation modified Story Memory Technique® (KF-mSMT®) (BEHAVIORAL), Aerobic Exercise Training (AET) plus Virtual Reality (IDEAL) (BEHAVIORAL), Stretching and Toning (S/T) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06197685?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06197685 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.